See other companies on Welcome to the Jungle
Nucleus
Consumer genetic testing & analysis
- 1-20 employees
- B2C
- Retail
- Biology
- Data Analysis
- Science
- Lower Manhattan, New York, NY
Jump to section
Company mission
Nucleus’ mission is to empower people to take agency over their health so no one dies from preventable disease.
Few candidates hear
back within 2 weeks
Our take
The decoding of the complete human genome in 2022 marked a crowning achievement for the field of genomics, which has seen some of the most significant milestone events in all of biology. Nucleus is a natural extension of humanity’s genetics obsession. By combining polygenic scores with traditional rare variant DNA analysis, the company provides comprehensive assessments of genetic disposition across a myriad of diseases and traits.
The hope is that, through enough consumer testing, Nucleus will become an important feature in the move to personalise healthcare based on genetics. Interestingly, the company is acutely aware of the lack of diversity in genomic datasets, and is looking to help gradually fix this issue by making their reports accessible, informative, and inclusive.
With its unique polygenic testing, Nucleus is breaking ground in the space, operating beyond other consumer DNA analysis brands like Ancestry and 23andme. The company has seen good funding which will enable it to build up its operational infrastructure, as well as hire into its scientific and engineering teams.
Freddie
Company Specialist at Welcome to the Jungle
Benefits
- Generous PTO
- Technology stipends and office perks
- Comprehensive healthcare, dental, and vision plans
- 401k employee plan
- Equity
Funding (2 rounds)
Jul 2022
$14m
SEED
Dec 2021
$3.5m
SEED
Total funding: $17.5m
This company has top investors
Leadership
Kian Sadeghi
(CEO)Former Research Fellow at Genspace NYCCollege. Dropped out from the University of Pennsylvania in 2020.